drugset
drugset / Trial / NCT00141544

The Efficacy of ESTRATEST® Tablets in Relieving Menopausal Symptoms in Estrogenized, Non-Hysterectomized Postmenopausal Women

NCT00141544 ↗

Phase 2 Terminated 28 enrolled Solvay Pharmaceuticals
RandomizedParallel-groupDouble-blindTreatment

Summary

To determine whether treatment with ESTRATEST® Tablets is superior to treatment with esterified estrogens tablets

Timeline

Start
2004-07
Primary completion
2007-04
Completion
2008-03

Drugs

EvaluationDrugModalityDoseRoute
Comparator ESTROGENS, ESTERIFIED Unknown 1.25 mg Oral
Subject methyltestosterone Small molecule 2.5 mg Oral

Indications

No indication recorded.